Med-Chemist : "Quintessential Medicinal Chemistry"
Friday, March 20, 2015
Drug stimulates brown fat, boosts metabolism
›
We know that, Mirabegron (formerly YM-178, trade name Myrbetriq, Betmiga in Spain) is a drug for the treatment of overactive bladd...
Thursday, March 19, 2015
New version of common antibiotic could eliminate risk of hearing loss
›
"All I remember is coming out of treatment not being able to hear anything," said Bryce, now a healthy 14-year-old living in Ari...
Wednesday, March 18, 2015
New treatment approach may improve survival rates for certain patients with stage 4 lung cancer
›
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates f...
Tuesday, March 17, 2015
Honey offers new approach to fighting antibiotic resistance ............
›
In continuation of my update on Honey.. Honey, that delectable condiment for breads and fruits, could be one sweet solution to t...
Monday, March 16, 2015
Newron, Zambon announce re-submission of safinamide NDA to FDA
›
In continuation of my update on safinamide Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company f...
Friday, March 13, 2015
Can-Fite BioPharma completes RA Phase III study of lead drug candidate CF101
›
Can-Fite BioPharma Ltd. a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and...
Thursday, March 12, 2015
Combination of bedaquiline and verapamil reduces side effects, improves outcomes for TB patients
›
In continuation of my update on Bedaquiline While an effective treatment is available for combating multidrug-resistant tuberculosis,...
2 comments:
Wednesday, March 11, 2015
FDA approves Myriad’s BRACAnalysis CDx for use with ovarian cancer drug
›
In continuation of my update on Olaparib Myriad Genetics, Inc. announced that it has received approval from the U.S. Food and Drug ...
Tuesday, March 10, 2015
Final Phase 1 data of zoptarelin doxorubicin Phase 1/2 trial published in Clinical Cancer Research
›
Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company") announced that an article on final data for the Phase 1 po...
Monday, March 9, 2015
Broccoli can help reduce HGPS-related defects
›
In continuation of my update on broccoli ... Children who suffer from Hutchinson-Gilford Progeria syndrome age prematurely due to a de...
Friday, March 6, 2015
Ganciclovir drug resistance may occur more frequently in cystic fibrosis patients
›
A drug called ganciclovir is given to lung transplant patients to protect against a life-threatening virus that is common after tr...
Thursday, March 5, 2015
Palatin begins bremelanotide phase 3 study for treatment of female sexual dysfunction
›
Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics ...
Wednesday, March 4, 2015
Can-Fite BioPharma begins dosing in CF102 Phase II liver cancer trial
›
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and i...
Tuesday, March 3, 2015
Intriguing small molecule directs activity of key ‘clock proteins’
›
In research published in Nature Communications , Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis...
Monday, March 2, 2015
Actavis receives complete response letter for nebivolol/valsartan FDC for treatment of hypertension
›
In continuation of my update on Valsartan Actavis plc , confirmed that the Company has received a complete response letter from the ...
1 comment:
‹
›
Home
View web version